NAICS
325412 Pharmaceutical Preparation ManufacturingThis U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
ROBERT KUPPER | Agent | 74 JUNIPER DRIVE, WEST WARWICK, RI, 02893-2308, USA |
Name | Role | Address |
---|---|---|
ROBERT JOE KUPPER PHD | CEO/DIRECTOR | 74 JUNIPER DR WEST WARWICK, RI 02893 USA |
Name | Role | Address |
---|---|---|
AKWETE LEX ADJEI PHD | VICE PRESIDENT/DIRECTOR | 125 BAILEY BLVD EAST GREENWICH, RI 02818 USA |
IOK-HOU PANG PHD | VICE PRESIDENT/DIRECTOR | 125STARBRIDGE LN GRAND PRAIRIE, TX 75052 USA |
Name | Role | Address |
---|---|---|
PING WU CHANG PHD | COO/DIRECTOR | 11 TRUNBULL RD WATERFORD, CT 06385 USA |
Name | Role | Address |
---|---|---|
JODI BRICHAN | DIRECTOR | 2407 ANACAPA ST SANTA BARBARA, CA 93105 USA |
A CIK (Central Index Key) number is a unique identifier assigned by the U.S. Securities and Exchange Commission (SEC) to companies that: Are publicly
traded on U.S. stock exchanges, File reports with the SEC.
Note: Having a CIK number indicates that: The company is registered with the SEC, Files regular financial reports (like 10-K, 10-Q), Must
comply with federal securities laws and regulations, Has public shareholders, Makes financial information publicly available through SEC's EDGAR
database.
Number | Name | File Date |
---|---|---|
202452888470 | Annual Report | 2024-04-28 |
202340088650 | Statement of Change of Registered/Resident Agent Office | 2023-08-02 |
202332993450 | Annual Report | 2023-04-14 |
202221401950 | Annual Report | 2022-07-18 |
202220266550 | Revocation Notice For Failure to File An Annual Report | 2022-06-27 |
Date of last update: 14 May 2025
Sources: Rhode Island Department of State